-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Finance App News, Fosun Pharmaceutical (600196.SH) issued an announcement. Recently, the company's holding subsidiary, Fosun Wanbang (Jiangsu) Pharmaceutical Group Co., Ltd.'s application for drug registration of englizin metformin sustained-release tablets (III) was approved by the State Drug Administration. The approved indications are in combination with diet control and exercise, for adult patients with type 2 diabetes who are being treated with empagliflozin and metformin hydrochloride to improve blood sugar control in these patients.

Zhitongcaijing·08/03/2026 08:41:09
Listen to the news
Zhitong Finance App News, Fosun Pharmaceutical (600196.SH) issued an announcement. Recently, the company's holding subsidiary, Fosun Wanbang (Jiangsu) Pharmaceutical Group Co., Ltd.'s application for drug registration of englizin metformin sustained-release tablets (III) was approved by the State Drug Administration. The approved indications are in combination with diet control and exercise, for adult patients with type 2 diabetes who are being treated with empagliflozin and metformin hydrochloride to improve blood sugar control in these patients.